Bastide Le Confort Médical SA (0IP1.L)
EUR 23.85
(-0.63%)
EUR 23.85
(-0.63%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -900 Thousand EUR | -105.6% |
| 2023 | 16.06 Million EUR | 17.43% |
| 2022 | 13.68 Million EUR | 1.7% |
| 2021 | 13.45 Million EUR | 15.97% |
| 2020 | 11.6 Million EUR | 153.94% |
| 2019 | 4.56 Million EUR | -36.18% |
| 2018 | 7.15 Million EUR | 31.94% |
| 2017 | 5.42 Million EUR | -24.48% |
| 2016 | 7.18 Million EUR | 5.65% |
| 2015 | 6.8 Million EUR | 32.94% |
| 2014 | 5.11 Million EUR | 23.76% |
| 2013 | 4.13 Million EUR | 17.51% |
| 2012 | 3.51 Million EUR | 9.97% |
| 2011 | 3.19 Million EUR | 12.01% |
| 2010 | 2.85 Million EUR | 27.23% |
| 2009 | 2.24 Million EUR | -61.9% |
| 2008 | 5.88 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -1.99 Million EUR | 0.0% |
| 2024 Q4 | 1.09 Million EUR | 0.0% |
| 2023 Q2 | 8.95 Million EUR | 0.0% |
| 2023 FY | 16.06 Million EUR | 17.43% |
| 2023 Q4 | 7.11 Million EUR | 0.0% |
| 2022 FY | 13.68 Million EUR | 1.7% |
| 2022 Q4 | 8.11 Million EUR | 0.0% |
| 2022 Q2 | 5.56 Million EUR | 0.0% |
| 2021 Q4 | 7.71 Million EUR | 0.0% |
| 2021 Q2 | 5.73 Million EUR | 0.0% |
| 2021 FY | 13.45 Million EUR | 15.97% |
| 2020 Q2 | 6.11 Million EUR | 0.0% |
| 2020 Q4 | 5.48 Million EUR | 0.0% |
| 2020 FY | 11.6 Million EUR | 153.94% |
| 2019 Q4 | 826 Thousand EUR | 0.0% |
| 2019 FY | 4.56 Million EUR | -36.18% |
| 2019 Q2 | 5.03 Million EUR | 0.0% |
| 2018 FY | 7.15 Million EUR | 31.94% |
| 2018 Q4 | 3.7 Million EUR | 0.0% |
| 2018 Q2 | 3.45 Million EUR | 0.0% |
| 2017 Q2 | 3.45 Million EUR | 0.0% |
| 2017 FY | 5.42 Million EUR | -24.48% |
| 2017 Q4 | 1.96 Million EUR | 0.0% |
| 2016 FY | 7.18 Million EUR | 5.65% |
| 2016 Q2 | 3.64 Million EUR | 0.0% |
| 2016 Q4 | 3.53 Million EUR | 0.0% |
| 2015 FY | 6.8 Million EUR | 32.94% |
| 2015 Q2 | 3.73 Million EUR | 0.0% |
| 2015 Q4 | 3.06 Million EUR | 0.0% |
| 2014 FY | 5.11 Million EUR | 23.76% |
| 2014 Q4 | 2.56 Million EUR | 0.0% |
| 2014 Q2 | 2.54 Million EUR | 0.0% |
| 2013 Q4 | 2.01 Million EUR | 0.0% |
| 2013 Q2 | 2.11 Million EUR | 0.0% |
| 2013 FY | 4.13 Million EUR | 17.51% |
| 2012 Q4 | 879.25 Thousand EUR | 0.0% |
| 2012 Q3 | 879.25 Thousand EUR | 0.0% |
| 2012 FY | 3.51 Million EUR | 9.97% |
| 2012 Q2 | 879.25 Thousand EUR | 9.97% |
| 2012 Q1 | 799.5 Thousand EUR | 0.0% |
| 2011 Q1 | 713.75 Thousand EUR | 0.0% |
| 2011 Q2 | 799.5 Thousand EUR | 12.01% |
| 2011 Q3 | 799.5 Thousand EUR | 0.0% |
| 2011 Q4 | 799.5 Thousand EUR | 0.0% |
| 2011 FY | 3.19 Million EUR | 12.01% |
| 2010 Q3 | 713.75 Thousand EUR | 0.0% |
| 2010 Q4 | 713.75 Thousand EUR | 0.0% |
| 2010 Q2 | 713.75 Thousand EUR | 27.23% |
| 2010 FY | 2.85 Million EUR | 27.23% |
| 2010 Q1 | 561 Thousand EUR | 0.0% |
| 2009 Q4 | 561 Thousand EUR | 0.0% |
| 2009 Q3 | 561 Thousand EUR | 0.0% |
| 2009 Q2 | 561 Thousand EUR | -61.9% |
| 2009 Q1 | 1.47 Million EUR | 0.0% |
| 2009 FY | 2.24 Million EUR | -61.9% |
| 2008 FY | 5.88 Million EUR | 0.0% |
| 2008 Q4 | 1.47 Million EUR | 0.0% |
| 2008 Q3 | 1.47 Million EUR | 0.0% |
| 2008 Q2 | 1.47 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Cegedim SA | -7.4 Million EUR | 87.849% |
| Guerbet SA | 23.86 Million EUR | 103.771% |
| Nexus AG | 24.03 Million EUR | 103.745% |
| Revenio Group Oyj | 19.1 Million EUR | 104.71% |
| Drägerwerk AG & Co. KGaA | 110.43 Million EUR | 100.815% |
| Sartorius Aktiengesellschaft | 205.2 Million EUR | 100.439% |
| LNA Santé SA | 23.4 Million EUR | 103.845% |
| Siemens Healthineers AG | 1.94 Billion EUR | 100.046% |
| Medios AG | 18.81 Million EUR | 104.785% |
| Equasens Société anonyme | 47.04 Million EUR | 101.913% |
| Stratec SE | 13.06 Million EUR | 106.888% |